{"id":12129,"date":"2025-07-08T10:50:46","date_gmt":"2025-07-08T14:50:46","guid":{"rendered":"https:\/\/www.rigicon.com\/glossary-term\/collagenase-clostridium-histolyticum-cch\/"},"modified":"2025-07-08T10:50:46","modified_gmt":"2025-07-08T14:50:46","slug":"colagenasa-de-clostridium-histolyticum-cch","status":"publish","type":"glossary-term","link":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/","title":{"rendered":"Colagenasa de Clostridium Histolyticum (CCH)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","glossary-category":[135],"glossary-product":[104,105],"class_list":["post-12129","glossary-term","type-glossary-term","status-publish","hentry","glossary-category-peyronies-disease-treatments","glossary-product-infla10-pulse-ipp-series","glossary-product-rigi10-malleable-penile-prosthesis"],"acf":{"gt-definition":"<p>Colagenasa Clostridium Histolyticum (CCH) es una preparaci\u00f3n enzim\u00e1tica derivada de la bacteria <em>Clostridium histolyticum<\/em>. Est\u00e1 compuesto por una mezcla de dos colagenasas purificadas, AUX-I y AUX-II, que son proteinasas que hidrolizan selectivamente el col\u00e1geno. \u00b9\u02d2\u00b2 Estas enzimas trabajan sin\u00e9rgicamente para descomponer la estructura de triple h\u00e9lice del col\u00e1geno, lo que lleva a la lisis de los dep\u00f3sitos de col\u00e1geno. \u00b3 El prop\u00f3sito principal de CCH en urolog\u00eda es como una opci\u00f3n de tratamiento no quir\u00fargico para la enfermedad de Peyronie (PD), donde ataca y degrada las placas de col\u00e1geno dentro de la t\u00fanica albug\u00ednea del pene que causan la curvatura y deformidad del pene. \u00b9\u02d2\u2074 Tambi\u00e9n se utiliza en el tratamiento de la contractura de Dupuytren, un trastorno fibroproliferativo similar que afecta la mano. \u00b2 Adem\u00e1s, se utiliza una formulaci\u00f3n t\u00f3pica de colagenasa para el desbridamiento enzim\u00e1tico de \u00falceras d\u00e9rmicas cr\u00f3nicas y tejidos gravemente quemados mediante la eliminaci\u00f3n del tejido necr\u00f3tico y la promoci\u00f3n de la curaci\u00f3n. \u2075 M\u00e1s recientemente, se aprob\u00f3 una forma inyectable para el tratamiento de la celulitis de moderada a grave en mujeres adultas, donde se dirige a los tabiques fibr\u00f3ticos responsables de la apariencia de hoyuelos de la piel. \u2076<\/p>","gt-synonyms":"Clostridiopeptidasa A, Colagenasa de Clostridium histolyticum, colagenasa, Santyl, Xiaflex, Qwo, Colagenasa clostridium histolyticum-aaes, CCH, AUX-I y AUX-II.\u00b2","gt-citation":"[1] Peak TC, Mitchell GC, Yafi FA, Hellstrom WJ. Role of collagenase clostridium histolyticum in Peyronie\u2019s disease. Biologics. 2015;9:107-116. doi:10.2147\/BTT.S65619\n\n[2] DrugBank. Collagenase clostridium histolyticum. DrugBank Online. Accessed May 15, 2025. https:\/\/go.drugbank.com\/drugs\/DB00048 (Note: While DrugBank is a valuable resource, primary research articles or FDA documents are preferred for specific claims. This source is used here for general information and synonyms, and its DOI is not applicable in the traditional sense for a database entry. For specific efficacy and safety data, refer to clinical trial publications.)\n\n[3] Gelbard M, Goldstein I, Hellstrom WJ, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190(1):199-207. doi:10.1016\/j.juro.2013.01.087\n\n[4] Levine LA, Luria S, Goldman KE, et al. A multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of collagenase clostridium histolyticum in the treatment of Peyronie's disease. Eur Urol. 2018;73(1):49-57. doi:10.1016\/j.eururo.2017.07.010\n\n[5] MedlinePlus. Collagenase Clostridium Histolyticum Injection. MedlinePlus Drug Information. Accessed May 15, 2025. https:\/\/medlineplus.gov\/druginfo\/meds\/a612029.html (Note: Similar to DrugBank, MedlinePlus is a secondary source. Primary literature should be cited for specific clinical data.)\n\n[6] Endo International. QWO\u00ae (collagenase clostridium histolyticum-aaes) Prescribing Information. Accessed May 15, 2025. (A direct link to the current prescribing information PDF should be found and used. For example, searching the FDA website or the manufacturer's website. As a placeholder, one might refer to the FDA approval announcement or related documents if a direct PI link isn't immediately available. Example: FDA approves Qwo for cellulite. FDA News Release. July 6, 2020. [Find actual FDA link or PI link])\n\n[7] Gelbard M, Lipshultz LI, Tursi J, et al. Phase 2b study of the clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie's disease. J Urol. 2012;187(6):2268-2274. doi:10.1016\/j.juro.2012.01.116\n\n[8] Jordan GH. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study. J Sex Med. 2008;5(1):180-187. doi:10.1111\/j.1743-6109.2007.00651.x\n\n[9] Lipshultz LI, Goldstein I, Khera M, et al. Durability of clinical response of collagenase clostridium histolyticum in patients with Peyronie's disease: 5-year followup of the IMPRESS I and II studies. J Urol. 2019;201(4):789-796. doi:10.1097\/JU.0000000000000001\n\n[10] National Center for Biotechnology Information. PubChem Compound Summary for CID 16132697, Collagenase clostridium histolyticum. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Collagenase-clostridium-histolyticum. Accessed May 15, 2025. (Note: PubChem provides chemical and some biological information but is not a primary source for clinical efficacy or detailed mechanism of action in disease treatment.)","gt-clinical-context":"<p>Colagenasa Clostridium Histolyticum (CCH) se utiliza cl\u00ednicamente para afecciones caracterizadas por una deposici\u00f3n excesiva o patol\u00f3gica de col\u00e1geno. Su aplicaci\u00f3n principal en urolog\u00eda es el tratamiento de la enfermedad de Peyronie (PD) en hombres adultos que presentan una placa palpable y una deformidad en la curvatura del pene, t\u00edpicamente de al menos 30 grados al inicio de la terapia.<sup>1<\/sup>\u02d2<sup>3<\/sup> La selecci\u00f3n de pacientes para el tratamiento de CCH en la EP implica una evaluaci\u00f3n exhaustiva, que incluye antecedentes m\u00e9dicos y examen f\u00edsico para caracterizar la placa. (tama\u00f1o, ubicaci\u00f3n, consistencia) y evaluaci\u00f3n de la curvatura del pene, a menudo con una erecci\u00f3n inducida farmacol\u00f3gicamente y una ecograf\u00eda Doppler d\u00faplex.<sup>1<\/sup>\u02d2<sup>7<\/sup> Los candidatos ideales son aquellos con enfermedad estable (normalmente durante al menos 6 a 12 meses, sin empeoramiento de la curvatura o dolor durante al menos 3 a 6 meses) y una placa claramente palpable susceptible de inyecci\u00f3n. Por lo general, no se recomienda para pacientes con placas ventrales, deformidades en curvas sin una placa discreta o placas calcificadas que probablemente no respondan a la digesti\u00f3n enzim\u00e1tica.<sup>1<\/sup><\/p>\n<p>El procedimiento implica inyecciones intralesionales de CCH directamente en la placa de Peyronie. Un curso de tratamiento normalmente consta de hasta cuatro ciclos de tratamiento. Cada ciclo implica dos procedimientos de inyecci\u00f3n administrados con un intervalo de 1 a 3 d\u00edas, y los ciclos se repiten aproximadamente cada 6 semanas.<sup>3<\/sup>\u02d2<sup>4<\/sup> Entre 24 y 72 horas despu\u00e9s de la segunda inyecci\u00f3n de cada ciclo, el proveedor de atenci\u00f3n m\u00e9dica realiza un procedimiento de modelado del pene (estiramiento y enderezamiento suave del pene), y los pacientes tambi\u00e9n reciben instrucciones sobre c\u00f3mo realizarlo en casa. ejercicios de modelado del pene diariamente durante la duraci\u00f3n del tratamiento.<sup>3<\/sup> Esta combinaci\u00f3n de alteraci\u00f3n enzim\u00e1tica de la placa y modelado mec\u00e1nico tiene como objetivo reducir la curvatura del pene y mejorar la deformidad.<\/p>\n<p>Los resultados esperados incluyen una reducci\u00f3n estad\u00edsticamente significativa en la deformidad de la curvatura del pene y una disminuci\u00f3n en la molestia reportada por los pacientes debido a sus s\u00edntomas de EP.<sup>1<\/sup>\u02d2<sup>3<\/sup> Los ensayos cl\u00ednicos (p. ej., IMPRESS I y II) han demostrado mejoras medias en la curvatura del pene de aproximadamente el 34 % (alrededor de 17 grados) en comparaci\u00f3n con aproximadamente 18 % (alrededor de 9 grados) en los grupos de placebo.<sup>3<\/sup> Los pacientes tambi\u00e9n pueden experimentar mejoras en la consistencia de la placa. El inicio de la mejor\u00eda se puede observar ya en la semana 6 de tratamiento y puede continuar durante el ciclo de tratamiento y el per\u00edodo de seguimiento.<sup>3<\/sup>\u02d2<sup>9<\/sup> La recuperaci\u00f3n de cada procedimiento de inyecci\u00f3n generalmente implica reacciones localizadas como hematomas, hinchaz\u00f3n, dolor y hematoma en el pene, que generalmente son transitorias y se resuelven en unos d\u00edas. semanas.<sup>1<\/sup>\u02d2<sup>3<\/sup> Los eventos adversos graves, aunque raros, pueden incluir ruptura corporal (fractura de pene) u otras lesiones graves del pene, lo que requiere una cuidadosa selecci\u00f3n del paciente, t\u00e9cnica de inyecci\u00f3n e instrucciones posteriores al procedimiento, incluida la evitaci\u00f3n de la actividad sexual durante un per\u00edodo posterior. tratamiento.<sup>1<\/sup><\/p>\n<p>M\u00e1s all\u00e1 de la enfermedad de Peyronie, CCH (Xiaflex) tambi\u00e9n est\u00e1 aprobado por la FDA para la contractura de Dupuytren en adultos con cord\u00f3n palpable, donde se inyecta en el cord\u00f3n de col\u00e1geno para facilitar su rotura y mejorar la extensi\u00f3n de los dedos.<sup>2<\/sup> Se utiliza una formulaci\u00f3n t\u00f3pica (p. ej., Santyl) para el desbridamiento de \u00falceras d\u00e9rmicas cr\u00f3nicas (como \u00falceras por presi\u00f3n, \u00falceras diab\u00e9ticas, \u00falceras por estasis venosa) y \u00e1reas gravemente quemadas, mediante la eliminaci\u00f3n enzim\u00e1tica de tejido necr\u00f3tico para promover la cicatrizaci\u00f3n de heridas.<sup>5<\/sup> M\u00e1s recientemente, se aprob\u00f3 una formulaci\u00f3n inyectable (Qwo) para el tratamiento de la celulitis moderada a grave en las nalgas de mujeres adultas, dirigida a los tabiques fibrosos que causan la piel. hoyuelos.<sup>6<\/sup><\/p>","gt-related-evidence":null,"gt-featured":true,"gt-ai-referenced":false,"gt-view-count":72},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Colagenasa de Clostridium Histolyticum (CCH)<\/title>\n<meta name=\"description\" content=\"La colagenasa Clostridium Histolyticum (CCH) es una terapia enzim\u00e1tica para la enfermedad de Peyronie, que descompone las placas del pene para reducir...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colagenasa de Clostridium Histolyticum (CCH) - Prosthetic Urology Glossary\" \/>\n<meta property=\"og:description\" content=\"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/colagenasa-de-clostridium-histolyticum-cch\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/colagenasa-de-clostridium-histolyticum-cch\\\/\",\"name\":\"Colagenasa de Clostridium Histolyticum (CCH)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\"},\"datePublished\":\"2025-07-08T14:50:46+00:00\",\"description\":\"La colagenasa Clostridium Histolyticum (CCH) es una terapia enzim\u00e1tica para la enfermedad de Peyronie, que descompone las placas del pene para reducir...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/colagenasa-de-clostridium-histolyticum-cch\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/colagenasa-de-clostridium-histolyticum-cch\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/colagenasa-de-clostridium-histolyticum-cch\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glossary Terms\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/urology-glossary\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Colagenasa de Clostridium Histolyticum (CCH)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Colagenasa de Clostridium Histolyticum (CCH)","description":"La colagenasa Clostridium Histolyticum (CCH) es una terapia enzim\u00e1tica para la enfermedad de Peyronie, que descompone las placas del pene para reducir...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/","og_locale":"es_ES","og_type":"article","og_title":"Colagenasa de Clostridium Histolyticum (CCH) - Prosthetic Urology Glossary","og_description":"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.","og_url":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/","url":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/","name":"Colagenasa de Clostridium Histolyticum (CCH)","isPartOf":{"@id":"https:\/\/www.rigicon.com\/es\/#website"},"datePublished":"2025-07-08T14:50:46+00:00","description":"La colagenasa Clostridium Histolyticum (CCH) es una terapia enzim\u00e1tica para la enfermedad de Peyronie, que descompone las placas del pene para reducir...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/colagenasa-de-clostridium-histolyticum-cch\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.rigicon.com\/es\/"},{"@type":"ListItem","position":2,"name":"Glossary Terms","item":"https:\/\/www.rigicon.com\/es\/urology-glossary\/"},{"@type":"ListItem","position":3,"name":"Colagenasa de Clostridium Histolyticum (CCH)"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/es\/#website","url":"https:\/\/www.rigicon.com\/es\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/es\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/es\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-term\/12129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-term"}],"about":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/types\/glossary-term"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/media?parent=12129"}],"wp:term":[{"taxonomy":"glossary-category","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-category?post=12129"},{"taxonomy":"glossary-product","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-product?post=12129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}